{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:39:52Z","timestamp":1782232792981,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,5,23]]},"DOI":"10.1038\/s41388-026-03735-7","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T05:29:19Z","timestamp":1775453359000},"page":"1729-1740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation"],"prefix":"10.1038","volume":"45","author":[{"given":"Mengqing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-2306","authenticated-orcid":false,"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3735_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3735_CR2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"3735_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-023-06234-x","volume":"619","author":"HA Abdel-Hafiz","year":"2023","unstructured":"Abdel-Hafiz HA, Schafer JM, Chen X, Xiao T, Gauntner TD, Li Z, et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature. 2023;619:624\u201331.","journal-title":"Nature"},{"key":"3735_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84:176\u201390.","journal-title":"Eur Urol"},{"key":"3735_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol. 2022;5:628\u201339.","journal-title":"Eur Urol Oncol"},{"key":"3735_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/jpm13050756","volume":"13","author":"SK Mohanty","year":"2023","unstructured":"Mohanty SK, Lobo A, Mishra SK, Cheng L. Precision Medicine in Bladder Cancer: Present Challenges and Future Directions. J Pers Med. 2023;13:756.","journal-title":"J Pers Med"},{"key":"3735_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, et al. NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 2.2022. J Natl Compr Canc Netw. 2022;20:866\u201378.","journal-title":"J Natl Compr Canc Netw"},{"key":"3735_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1476","volume":"9","author":"LM Urbanski","year":"2018","unstructured":"Urbanski LM, Leclair N, Anczuk\u00f3w O. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018;9:e1476.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3735_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrg3052","volume":"12","author":"A Kalsotra","year":"2011","unstructured":"Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 2011;12:715\u201329.","journal-title":"Nat Rev Genet"},{"key":"3735_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.molmed.2012.06.006","volume":"18","author":"RK Singh","year":"2012","unstructured":"Singh RK, Cooper TA. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 2012;18:472\u201382.","journal-title":"Trends Mol Med"},{"key":"3735_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/cancers16061195","volume":"16","author":"J Duex","year":"2024","unstructured":"Duex J, Theodorescu D. CD44 in Bladder Cancer. Cancers. 2024;16:1195.","journal-title":"Cancers"},{"key":"3735_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1760","volume":"14","author":"AJ Montero-Hidalgo","year":"2023","unstructured":"Montero-Hidalgo AJ, P\u00e9rez-G\u00f3mez JM, Mart\u00ednez-Fuentes AJ, G\u00f3mez-G\u00f3mez E, Gahete MD, Jim\u00e9nez-Vacas JM, et al. Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment. Wiley Interdiscip Rev RNA. 2023;14:e1760.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3735_CR13","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.7150\/thno.67409","volume":"12","author":"C Gaiteiro","year":"2022","unstructured":"Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, et al. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion. Theranostics. 2022;12:3150\u201377.","journal-title":"Theranostics"},{"key":"3735_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ymthe.2020.08.018","volume":"29","author":"R Xie","year":"2021","unstructured":"Xie R, Chen X, Cheng L, Huang M, Zhou Q, Zhang J, et al. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR. Mol Ther. 2021;29:291\u2013307.","journal-title":"Mol Ther"},{"key":"3735_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-022-02558-0","volume":"41","author":"X Liu","year":"2022","unstructured":"Liu X, Zheng Y, Xiao M, Chen X, Zhu Y, Xu C, et al. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis. J Exp Clin Cancer Res. 2022;41:353.","journal-title":"J Exp Clin Cancer Res"},{"key":"3735_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang SY, et al. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15:1829\u201352.","journal-title":"Nat Protoc"},{"key":"3735_CR17","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","volume":"66","author":"L Xiang","year":"2021","unstructured":"Xiang L, Zeng Q, Liu J, Xiao M, He D, Zhang Q, et al. MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. Sci Bull(Beijing). 2021;66:1773\u201388.","journal-title":"Sci Bull(Beijing)"},{"key":"3735_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.241","volume":"10","author":"M Xiao","year":"2020","unstructured":"Xiao M, Liu J, Xiang L, Zhao K, He D, Zeng Q, et al. MAFG-AS1 promotes tumor progression via regulation of the HuR\/PTBP1 axis in bladder urothelial carcinoma. Clin Transl Med. 2020;10:e241.","journal-title":"Clin Transl Med"},{"key":"3735_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1261\/rna.078879.121","volume":"27","author":"L Shkreta","year":"2021","unstructured":"Shkreta L, Delannoy A, Salvetti A, Chabot B, et al. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication. RNA. 2021;27:1302\u201317.","journal-title":"RNA"},{"key":"3735_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01502-2","volume":"21","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yan Q, Mo Y, Liu Y, Wang Y, Zhang S, et al. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1\/c-Myc positive feedback loop. Mol Cancer. 2022;21:62.","journal-title":"Mol Cancer"},{"key":"3735_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20360-x","volume":"8","author":"A Cloutier","year":"2018","unstructured":"Cloutier A, Shkreta L, Toutant J, Durand M, Thibault P, Chabot B. hnRNP A1\/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage. Sci Rep. 2018;8:2206.","journal-title":"Sci Rep"},{"key":"3735_CR22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.celrep.2016.10.071","volume":"17","author":"L Shkreta","year":"2016","unstructured":"Shkreta L, Toutant J, Durand M, Manley JL, Chabot B. SRSF10 connects DNA damage to the alternative splicing of transcripts encoding apoptosis, cell-cycle control, and DNA repair factors. Cell Rep. 2016;17:1990\u20132003.","journal-title":"Cell Rep"},{"key":"3735_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13046-023-02614-3","volume":"42","author":"J Lv","year":"2023","unstructured":"Lv J, Li K, Yu H, Han J, Zhuang J, Yu R, et al. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway. J Exp Clin Cancer Res. 2023;42:41.","journal-title":"J Exp Clin Cancer Res"},{"key":"3735_CR24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3390\/cancers15041150","volume":"15","author":"Y Gao","year":"2023","unstructured":"Gao Y, Cao H, Huang D, Zheng L, Nie Z, Zhang S. RNA-Binding Proteins in Bladder Cancer. Cancers. 2023;15:1150.","journal-title":"Cancers"},{"key":"3735_CR25","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41388-017-0119-6","volume":"37","author":"F Liu","year":"2018","unstructured":"Liu F, Dai M, Xu Q, Zhu X, Zhou Y, Jiang S, et al. SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-\u03baB-CD47 axis. Oncogene. 2018;37:2394\u2013409.","journal-title":"Oncogene"},{"key":"3735_CR26","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1007\/s00432-023-04673-7","volume":"149","author":"SY Chen","year":"2023","unstructured":"Chen SY, Cao JL, Li KP, Wan S, Yang L. BIN1 in cancer: biomarker and therapeutic target. J Cancer Res Clin Oncol. 2023;149:7933\u201344.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3735_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/hep.31062","volume":"72","author":"Z Hu","year":"2020","unstructured":"Hu Z, Dong L, Li S, Li Z, Qiao Y, Li Y, et al. Splicing Regulator p54(nrb) \/Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma. Hepatology. 2020;72:548\u201368.","journal-title":"Hepatology"},{"key":"3735_CR28","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/onc.2017.217","volume":"36","author":"J Wang","year":"2017","unstructured":"Wang J, Jia Y, Zhao S, Zhang X, Wang X, Han X, et al. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR\/MAPK signaling pathways in non-small cell lung cancer. Oncogene. 2017;36:6235\u201343.","journal-title":"Oncogene"},{"key":"3735_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08076-y","volume":"10","author":"Y Ge","year":"2019","unstructured":"Ge Y, Schuster MB, Pundhir S, Rapin N, Bagger FO, Sidiropoulos N, et al. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia. Nat Commun. 2019;10:172.","journal-title":"Nat Commun"},{"key":"3735_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20150415","volume":"130","author":"Z Boudhraa","year":"2016","unstructured":"Boudhraa Z, Bouchon B, Viallard C, D\u2019Incan M, Degoul F. Annexin A1 localization and its relevance to cancer. Clin Sci. 2016;130:205\u201320.","journal-title":"Clin Sci"},{"key":"3735_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ccell.2023.03.001","volume":"41","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhu S, Liu T, Zhang S, Lu J, Fan W, et al. Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell. 2023;41:903\u201318.e8.","journal-title":"Cancer Cell"},{"key":"3735_CR32","doi-asserted-by":"publisher","first-page":"e2409726","DOI":"10.1002\/advs.202409726","volume":"11","author":"G Shao","year":"2024","unstructured":"Shao G, Wang X, Zheng Y, Ma J, Wang L, Yan Z, et al. Identification of ANXA1 as a Novel Upstream Negative Regulator of Notch1 Function in AML. Adv Sci. 2024;11:e2409726.","journal-title":"Adv Sci"},{"key":"3735_CR33","first-page":"5538","volume":"7","author":"S Yu","year":"2014","unstructured":"Yu S, Meng Q, Hu H, Zhang M. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer. Int J Clin Exp Pathol. 2014;7:5538\u201348.","journal-title":"Int J Clin Exp Pathol"},{"key":"3735_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02427-4","volume":"22","author":"P Li","year":"2022","unstructured":"Li P, Li L, Li Z, Wang S, Li R, Zhao W, et al. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell Int. 2022;22:7.","journal-title":"Cancer Cell Int"},{"key":"3735_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01175-z","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Huang Z, Cao X, Zhang F, Cai J, Tang P, et al. A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer. BMC Urol. 2023;23:10.","journal-title":"BMC Urol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03735-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T22:23:39Z","timestamp":1777847019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03735-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":35,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,5,23]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03735-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the ethics committee of the Third Xiangya Hospital of Central South University (No. 2021-S141). All the animals received human care. Ten human bladder cancer specimens were collected from the Third Xiangya Hospital of Central South University between January 2019 and December 2023, and patient consent was waived due to the retrospective design of the study and approval from the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}